Montecito Bank & Trust Cytom X Therapeutics, Inc. Transaction History

Montecito Bank & Trust

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 11, 2018	SELL	$18.04 - $26.41 $388,960 - $569,426	-21,561 Closed	0 $0
Q2 2018 Aug 02, 2018	SELL	$21.38 - $29.68 $49,195 - $68,293	-2,301 Reduced 9.64%	21,561 $493,000
Q1 2018 Apr 23, 2018	BUY	$21.76 - $34.22 $519,237 - $816,557	23,862 New	23,862 $679,000
Q4 2017 Feb 13, 2018	SELL	$19.0 - $23.09 $486,438 - $591,150	-25,602 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$19.0 - $23.09 $57,000 - $69,270	-3,000 Reduced 10.49%	25,602 $540,000
Q3 2017 Oct 23, 2017	BUY	$13.53 - $18.17 $386,985 - $519,698	28,602	28,602 $520,000

50.2M

22.3K

22.9K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $74.5M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Montecito Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Montecito Bank & Trust with notifications on news.